Physician

Michael J Messingham, MD

According to 2025 Medicare claims, Michael Messingham, MD (NPI: 1558355859) practices dermatology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is ACCREDITED DERMATOLOGY ASSOCIATES, P.C. (NPI: 1326176983; TIN: 42-1163408) and primary practice location at 52807-7205. Messingham is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799), participating under the MSSP model.

Messingham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,171 traditional Medicare patients, billed 6,469 HCPCS/CPT codes, and received $277,933 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 57 prescription claims across 40 beneficiaries totaling $10,012 in drug costs, led by Fluocinonide (Fluocinonide). Open Payments data shows 7 records totaling $149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $9,895 to $10,012. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,277	7,706	$393,820
2016	1,329	7,563	$363,583
2017	1,365	7,690	$364,163
2018	1,574	7,860	$341,822
2019	1,545	8,330	$399,125
2020	1,389	6,564	$303,501
2021	1,332	6,565	$357,417
2022	1,260	6,659	$339,032
2023	1,295	6,660	$340,460
2024	1,171	6,469	$277,933

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	66	$9,895
2016	43	60	$2,467
2017	48	64	$2,705
2018	46	56	$2,613
2019	50	68	$2,325
2020	18	32	$929
2021	N/R	12	$456
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	40	57	$10,012

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	294	361	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	664	845	$47
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	557	787	$32
17000	Destruction of precancer skin growth, 1 growth	636	934	$30
17003	Destruction of precancer skin growth, 2-14 growths	482	2,393	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluocinonide	Fluocinonide	11	275	$455

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$149	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael J. Messingham, MD?

Tedicare shows public-source Medicare data for Michael J. Messingham, MD (NPI 1558355859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael J. Messingham, MD have ACO affiliation data?

Michael J. Messingham, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799).

What billing organization is linked to Michael J. Messingham, MD?

Michael J. Messingham, MD is linked to ACCREDITED DERMATOLOGY ASSOCIATES, P.C. (billing NPI 1326176983) in the available physician profile data.

Does Michael J. Messingham, MD have Open Payments data?

Michael J. Messingham, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.